| Milestone Payment of DKK 20 Million Triggered in Connection With Japanese New Drug Application Filing COPENHAGEN, Denmark, May 24, 2012 (GLOBE NEWSWIRE) -- Genmab A/S (Copenhagen:GEN) announced today a milestone payment of DKK 20 million from GlaxoSmithKline to Genmab in connection with the filing of the New Drug Application (NDA) to the Japanese Ministry of Health, Labor and Welfare (MHLW). The NDA is for Arzerra® (ofatumumab) for the treatment of patients with chronic lymphocytic leukemia...continued GNMSF GNMSY |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment